Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
Clinical trial NCT05285540 · COMPLETED
Trial details
- NCT number
- NCT05285540
- Sponsor
- Design Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2022-12-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.